Lexology January 23, 2018
Ropes & Gray LLP

On Tuesday, January 23, Ropes & Gray hosted a teleconference on the regulatory and compliance impact of the Trump Administration’s first year on life sciences and health care companies. The discussion featured the perspectives of life sciences partners Greg Levine, Kellie Combs, Al Cacozza, health care partner Tom Bulleit and government enforcement partner Colleen Conry. The call examined various issues, including:

  • Impact of new...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: ACA (Affordable Care Act), Biotechnology, CMS, Congress / White House, Cures Act, FDA, Healthcare System, HHS, Regulations, Value Based
How Are Telehealth CEOs Reacting to Congress’ Latest Spending Legislation?
Trump Administration Mass Canceling Science Grants, Causing Job Loss
Dr. Oz faces Senate: What he said on Medicaid, Medicare Advantage, prior authorization, and more
MedPAC pushes Congress for slight hospital pay bump in 2026
Trump just withdrew his CDC director nomination. Here's why.

Share This Article